Dragpharma

Species

Dogs.

Dosage form

Injectable solution

Therapeutic action

Hemostatic and Angioprotective.

Composition

Each 1 mL contains:
Ethamsylate ....................... 125 mg
Excipients q.s. ....................... 1 mL

Indications

Hemodrag^® is indicated for the prevention and treatment of hemorrhages in veterinary surgery, reproductive and obstetric pathologies, accidental trauma and localized hemorrhages in various organs. It has a hemostatic and angioprotective effect on dermal processes such as petechiae, hematomas and wounds.
Hemodrag^® is effective for all bleeding processes regardless of their etiology (with the exception of bleeding caused by coumarin agents), because it acts on primary hemostasis. In dogs it can be used for tail docking, castration and postpartum haemorrhages.

Route od administration and dosage

Administration by slow intravenous or deep intramuscular route.

Dose of the active principle:
5 to 12.5 mg / Kg of weight, in a single dose.

Product dosage:
0.4 to 1 mL / 10 Kg of weight, in a single dose.

Drug interactions

Do not use concomitantly with other pharmacological products.

Contraindications

• Do not administer in cases of acute porphyriasis, since it has been seen to be porphyrogenic in animals.
• Do not use in animals with known hypersensitivity to the active principle.

Special precautions for use

Special warnings and precautions for use

• Keep out of the reach of children.
• This product is indicated for the treatment of animals individually. Do not treat the entire mass of animals.
• Animals should not be slaughtered for human consumption during and / or immediately after treatment.
• The product oxidizes in the presence of oxygen, for which the remaining volume after administration must be discarded.
• In the case of intramuscular administration, if the required dose is greater than 20 mL, it is suggested to divide it into two or more application points.

Special precautions for the operator

• Administer with caution. Wash your hands after applying the product.
• People with known hypersensitivity to ethamsylate should avoid contact with the drug.
• Accidental self-injection can cause alteration of blood pressure. In case of occurrence, immediately consult a doctor and show the product label.

Observations

Overdose:
Studies carried out on the tolerance of ethamsylate indicate that the drug is well tolerated even in doses much higher than those recommended.

Special precautions for disposal of unused product or waste material:
Discard any unused product remains in its original container. Do not throw the empty container or with product remains, in rivers, lakes or streams of natural water. Dispose of the waste of this product with care together with household waste.

Conservation

Store at room temperature, between 15 ° C and 30 ° C, in a dry place protected from light. Once the container is opened, use within 1 week. Discard the unused product after that period of time.

Presentation

4 vials of 5 mL

Prepared by

Laboratorio Drag Pharma Chile Invetec S.A.

Records

Chile: Reg. SAG N° 1967
Perú: Reg. SENASA F.F3.01.I.0009

Countries where it is marketed

Imported and Distributed in Peru by:
Representaciones Durand SAC.
Av. Manuel Olguín No. 501 Office No. 604 Santiago de Surco Lima.